Walgreens Boots AllianceOn Thursday, analysts exceeded their expectations and the company raised its outlook for the year. Customers came into its stores to purchase Covid vaccines or testing.

Shares of the drugstore chain rose by more than 22% In premarket trading

This is what Walgreens reported, versus what analysts expected for the quarter ending Nov. 30. Based on data from Refinitiv:

• Earnings Per Share: $1.68 adjusted, vs. expected $1.33
• Revenue: Expected $33.90 billion, vs. $32.74 trillion

The quarter’s net income increased to $3.58 Billion, which is $4.13 per share. Comparable to a net loss in the same year of $308million, or 36cs per share

The company’s earnings were $1.68 per diluted share. Refinitiv surveyed analysts to estimate that $1.33 is the average.

Revenues rose to $33.90Billion A year earlier at $31.44 Billion, an increase on the forecast of $32.74 Billion by analysts.

Walgreens stock closed Wednesday up almost 1% at $54.00 Walgreens’ shares rose 31% in the last 12 months to close Wednesday at $54.00, nearly 1% higher than its previous closing price. This brings it to $46.74 trillion.